Gentamicin Appropriate Second-Line Therapy to Ceftriaxone for Gonorrhea
TUESDAY, May 7, 2019 -- A single dose of gentamicin is an appropriate second-line therapy for gonorrhea resistant to a single dose of ceftriaxone, according to a study published online May 2 in The Lancet. Jonathan D.C. Ross, M.D., from Birmingham... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 7, 2019 Category: Pharmaceuticals Source Type: news

Drug combination could be effective for treatment-resistant gonorrhea
(National Institute for Health Research) Scientists comparing treatments for gonorrhea have identified a drug combination that could be an effective back-up for patients not responding to current therapy. The research team, from University Hospitals Birmingham, found that a treatment of the antibiotic gentamicin with azithromycin worked almost as well as the currently used ceftriaxone for genital gonorrhea. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 2, 2019 Category: Infectious Diseases Source Type: news

Several antibiotics appear effective against early-stage Lyme disease
This meta-analysis suggests that when symptoms of the disease are confined to a localised skin infection, treatment failures are relatively infrequent, only 2% at 12 months. Effective antibiotics include penicillin V, doxycycline, azithromycin, cefuroxime, amoxicillin and ceftriaxone plus doxycycline.The research has significant limitations, but choice, dose and duration of antibiotics appear to have little impact on outcomes. This research does not suggest that guidelines need to be reviewed. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 15, 2019 Category: Consumer Health News Source Type: news

British Association for Sexual Health and HIV national guideline for the management of infection with Neisseria gonorrhoeae (2019)
Revisions to this guideline includes advice that, if antimicrobial susceptibility test results from all sites of infection are available prior to treatment and the isolate is sensitive to ciprofloxacin, then this should be used for treatment in preference to ceftriaxone. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 30, 2019 Category: Consumer Health News Source Type: news

Lupin, Sun Pharma, Glenmark recall products in US
Lupin is voluntarily recalling 55,000 vials and 1,60,241 boxes of anti-bacterial drug Ceftriaxone for injection in various strengths. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 20, 2019 Category: Pharmaceuticals Source Type: news

Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g
Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g and 3 lots of Ceftriaxone for Injection, USP 2g, to the hospital/physician level. The products have been found to contain visual grey particulate matter in reconstituted vials. (Source: Food and Drug Administration)
Source: Food and Drug Administration - January 6, 2019 Category: Food Science Source Type: news

Single Dose of New Oral Antibiotic Cures Most Gonorrhea Single Dose of New Oral Antibiotic Cures Most Gonorrhea
A single dose of oral zoliflodacin had efficacy similar to that of intramuscular ceftriaxone for uncomplicated urogenital and rectal gonococcal infections (but not pharyngeal gonococcal infections).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Lyme disease: NICE guideline [NG95]
This guideline covers diagnosing and managing Lyme disease. It aims to raise awareness of when Lyme disease should be suspected and ensure that people have prompt and consistent diagnosis and treatment. It does not cover preventing Lyme disease. The guideline was updated in October 2018. Treatment for Lyme carditis in haemodynamically unstable children aged 9-12 was changed to IV ceftriaxone. First alternative was changed to oral doxycycline (DX). Footnote was added on using clinical judgement to determine doses of DX in children (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 19, 2018 Category: Consumer Health News Source Type: news

What is the Blood Culture Recovery Rate After Antibiotic Pretreatment?
Discussion Sepsis is an inflammatory response syndrome in the presence of an infection, it can be caused by bacteria, viruses or fungi. Bacteremia is the presence of bacteria in the blood. Studies from the US show an increased incidence of sepsis (0.56 to 0.89 cases/1000 children in all age groups) but a decreased fatality rate from 10.3% to 8.9%. The prevalence of severe sepsis in pediatric intensive care settings is reported in as many as 7.7% of admissions. Severe sepsis is more common when patients have co-morbities. Primary prevention includes immunization and appropriate precautions and procedures (i.e. catheter acce...
Source: PediatricEducation.org - October 1, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Drug Combo No Better for Hard-to-Treat Bloodstream Infections Drug Combo No Better for Hard-to-Treat Bloodstream Infections
A carbapenem-sparing option for the treatment of ceftriaxone-resistant infections was not equal to meropenem and should not be used in the setting of E coli or K pneumonia bloodstream infections.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2018 Category: Consumer Health News Tags: Hospital Medicine News Source Type: news

STDs on the Rise
Recently the Centers for Disease Control and Prevention (CDC) has reported the dramatic increase of sexually transmitted diseases in the U.S.  In fact, for the fourth year in a row the numbers have continued to rise. Among the rise, specific sexually transmitted diseases include: gonorrhea has been diagnosed in 555,608 cases in preliminary 2017 data (an increase of 67%  from 2013) syphilis has been diagnosed in 30,644 cases (an increase of 76% from 2013) chlamydia was reported with more than 1.7 million cases in 2017 These three diseases can be treated with antibiotics but gonorrhea has become antibiotic resist...
Source: Dragonfly - September 10, 2018 Category: Databases & Libraries Authors: Carolyn Martin Tags: Health Literacy/Consumer Health Public Health Public Libraries Source Type: news

Drug-resistance of gonorrhea in the EU: persistent but stable
(European Centre for Disease Prevention and Control (ECDC)) Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP). This threatens the effectiveness of the currently recommended dual therapy regimen for gonorrhea. Overall, the rates of resistance to cefixime, ceftriaxone and azithromycin have remained stable when compared to recent years. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 30, 2018 Category: Infectious Diseases Source Type: news

Avoid piperacillin-tazobactam when treating BSI cause by ceftriaxone-resistant pathogens
(European Society of Clinical Microbiology and Infectious Diseases) The antibiotic combination treatment piperacillin-tazobactam was significantly less effective than meropenem when treating potentially fatal bloodstream infections (BSI) caused by ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae and should be avoided when treating these organisms, according to research presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 21, 2018 Category: Biology Source Type: news

Family reaches $500K settlement with VA Medical Center
The family of a man who died after having a reaction to an antibiotic reached a half-million-dollar settlement with the Kansas City VA Medical Center. Craig Beemer told The Kansas City Star that he and his brother reached the settlement in a case against the Kansas City VA center. They sued the medical center after their father, John Beemer, died after suffering a severe reaction to the antibiotic Ceftriaxone. Beemer said he insisted on not sig ning a nondisclosure agreement to settle the suit,… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 9, 2018 Category: Health Management Source Type: news

Family reaches $500K settlement with VA Medical Center
The family of a man who died after having a reaction to an antibiotic reached a half-million-dollar settlement with the Kansas City VA Medical Center. Craig Beemer told The Kansas City Star that he and his brother reached the settlement in a case against the Kansas City VA center. They sued the medical center after their father, John Beemer, died after suffering a severe reaction to the antibiotic Ceftriaxone. Beemer said he insisted on not sig ning a nondisclosure agreement to settle the suit,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 9, 2018 Category: Biotechnology Source Type: news

How did gonorrhea become a drug-resistant superbug?
(University of North Carolina Health Care) UNC School of Medicine researchers have identified mutations to the bacterium Neisseria gonnorrhoeae that enable resistance to ceftriaxone that could lead to the global spread of ceftriaxone-resistant 'superbug' strains. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 4, 2018 Category: International Medicine & Public Health Source Type: news

The World ’s First Case of Drug-Resistant ‘Super Gonorrhea’ Has Been Confirmed
This report is one more confirmation of our greatest fear: drug-resistant gonorrhea spreading around the globe,” David Harvey, executive director of the National Coalition of STD Directors, told CNN. The patient, who first sought medical care in early 2018, is being treated with an intravenous course of ertapenem, a powerful antibiotic typically used, at least in the U.S., for “serious infections in hospitalized patients,” according to the National Institutes of Health. The results of his next test are expected in mid-April. Gonorrhea is one of the world’s most common STIs, affecting 78 million peop...
Source: TIME: Health - March 30, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime public health Source Type: news

U.K. Man Has World's Worst Case of Super-Gonorrhea
It's the first case of the sexually-transmitted disease that could not be cured with the main antibiotic treatment, a combination of azithromycin and ceftriaxone, according to Public Health England, BBC News reported. (Source: WebMD Health)
Source: WebMD Health - March 29, 2018 Category: Consumer Health News Source Type: news

How A Man Caught The World's Strongest Super Gonorrhea To Date
This is the first reported case in the world of N. gonorrhea which has both high-level resistance to azithromycin and resistance to ceftriaxone. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 29, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

How A Man Caught The World's Strongest Super Gonorrhea To Date
This is the first reported case in the world of N. gonorrhea which has both high-level resistance to azithromycin and resistance to ceftriaxone. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 29, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Gonorrhea in China shows waning susceptibility to WHO-recommended antibiotics
(PLOS) Neisseria gonorrhoeae strains resistant to azithromycin and/or with decreased susceptibility to ceftriaxone are common in China, according to a prevalence study published this week in PLOS Medicine. The study also showed that the prevalence of dual resistance in N. gonorrhoeae isolates increased from 2013 to 2016. The results suggest that dual therapy with azithromycin and ceftriaxone, recommended by WHO and many countries to treat gonorrhea, may not prove effective in China. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 6, 2018 Category: Infectious Diseases Source Type: news

Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial
This Dutch Randomised Controlled Trial (n=2698) found that ceftriaxone 200mg IV delivered in the ambulance did not improve 28 day mortality vs antibiotics initiated in the emergency department (ED) (8% vs 8%). It found that personnel training reduced the time to antibiotics delivered after arrival in the ED. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 6, 2017 Category: Consumer Health News Source Type: news

Your NEJM Group Today: Unintentional Overdose Case / Ceftriaxone-Resistant Gonorrhea in North America / Virginia Hospitalist Opportunity
Here's what we've chosen for you today: NEJM Clinical Practice Center: Case Record: A 36-year-old man was seen in the emergency department because... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 1, 2017 Category: Primary Care Source Type: news

Ceftriaxone (Ceftriaxone Sodium and Dextrose Injection ) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 18, 2017 Category: Drugs & Pharmacology Source Type: news

Azithromycin and Ceftriaxone Resistance in N gonorrhoeae Azithromycin and Ceftriaxone Resistance in N gonorrhoeae
Azithromycin and ceftriaxone are the recommended treatment options for Neisseria gonorrhoeae, but treatment failures have been reported.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 17, 2017 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Gonorrhea Becoming More Difficult To Treat With Antibiotics
CBS Local — Gonorrhea is becoming more difficult to treat with antibiotics and for some patients it’s become impossible, the World Health Organization (WHO) said. Three forms of bacteria known as “superbugs” that cannot be killed by the best available gonorrhea medicine have been detected in Spain, France and Japan, according to the WHO. “The bacteria that cause gonorrhea are particularly smart. Every time we use a new class of antibiotics to treat the infection, the bacteria evolve to resist them,” said Teodora Wi, a human reproduction specialist for the WHO, in a press release. Analysi...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 7, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Antibiotics Dan Corey Medicine STDs Source Type: news

Amoxicillin and Ceftriaxone for Maternal Syphilis Amoxicillin and Ceftriaxone for Maternal Syphilis
When penicillin is not available, should amoxicillin and ceftriaxone be considered as treatment options for maternal syphilis?Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 3, 2017 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Rapid Assay Revives Ciprofloxacin Use for Gonorrhea Rapid Assay Revives Ciprofloxacin Use for Gonorrhea
A pharmacogenomics approach identified gonorrhea infections susceptible to ciprofloxacin and allowed physicians to reserve ceftriaxone for resistant cases.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 3, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Scientists develop test to identify best treatment for gonorrhea
FINDINGSResearchers from UCLA have developed a laboratory test that helps physicians determine which people with gonorrhea may be more treatable with an antibiotic that has not been recommended since 2007 because of concerns that the resistance to the drug was growing.BACKGROUNDGonorrhea has developed increasing resistance to all current antibiotics. Due to the spread of multi-drug resistant gonorrhea, health authorities have declared it one of the top-three urgent threats to public health.Ciprofloxacin was used to combat the sexually transmitted infection until 2007, when the Centers for Disease Control and Prevention sto...
Source: UCLA Newsroom: Health Sciences - May 23, 2017 Category: Universities & Medical Training Source Type: news

Nigeria: PSN Donates Meningitis Drugs to Sokoto
[Daily Trust] Lagos -The national body of Pharmaceutical Society of Nigeria (PSN) has donated drugs (Inj. Ceftriaxone) to the Sokoto state government to help curb the scourge of meningitis epidemic in the state. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 15, 2017 Category: African Health Source Type: news

Rocephin (Ceftriaxone) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 11, 2017 Category: Drugs & Pharmacology Source Type: news

Tanzania: Powercef - Medicine Widely Used and 'Abused' in Tanzania
[Citizen] There is this popular and widely used antibiotic in Tanzania, known as Powercef whose generic name is Ceftriaxone. It's being prescribed 'irrationally' in the country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 5, 2017 Category: African Health Source Type: news

Incurable: Gonorrhea outbreak in Hawaii showing increased antibiotic resistance
(NaturalNews) At least seven patients from Hawaii are suffering from what health experts fear may eventually become an incurable outbreak of gonorrhea. The sexually-transmitted disease (STD) is typically treatable with antibiotic drugs like ceftriaxone and azithromycin, but growing... (Source: NaturalNews.com)
Source: NaturalNews.com - October 4, 2016 Category: Consumer Health News Source Type: news

Second Chance on Bladder US
“If you are given a second chance in life, don’t blow it,” you advise your eager resident. It has been an overwhelmingly busy day in the department. Interspersed between the motor vehicle collisions, hypoxic and hypotensive CHF exacerbations, and patients with florid sepsis, your team is trying to see and help all of the ankle pains, throat pains, and dysuria that have also walked through the waiting room doors. The neighborhood clinics are completely overbooked, and your department has been dealing with the overflow all week. Your resident has three charts in her hand and has just finished presenting the...
Source: EPMonthly.com - September 27, 2016 Category: Emergency Medicine Authors: Logan Plaster Tags: Uncategorized Source Type: news

Drug-Resistant Gonorrhea Strain In Hawaii A First For U.S.
A drug-resistant cluster of gonorrhea infections in Hawaii have health officials worried that the sexually transmitted disease could soon prove untreatable. The Centers for Disease Control and Prevention announced this week that an antibiotic-resistant strain was discovered earlier this year in seven patients in Honolulu. All the individuals ― six men and one woman ― were successfully treated using the CDC-recommended two-drug combination of ceftriaxone and azithromycin. Laboratory tests, however, showed the strain had “decreased susceptibility to ceftriaxone and very high-level resistance to azithromycin,”...
Source: Science - The Huffington Post - September 23, 2016 Category: Science Source Type: news

Drug-Resistant Gonorrhea Strain In Hawaii A First For U.S.
A drug-resistant cluster of gonorrhea infections in Hawaii have health officials worried that the sexually transmitted disease could soon prove untreatable. The Centers for Disease Control and Prevention announced this week that an antibiotic-resistant strain was discovered earlier this year in seven patients in Honolulu. All the individuals ― six men and one woman ― were successfully treated using the CDC-recommended two-drug combination of ceftriaxone and azithromycin. Laboratory tests, however, showed the strain had “decreased susceptibility to ceftriaxone and very high-level resistance to azithromycin,”...
Source: Healthy Living - The Huffington Post - September 23, 2016 Category: Consumer Health News Source Type: news

CDC Finds First Cluster of Highly Resistant Gonorrhea in US CDC Finds First Cluster of Highly Resistant Gonorrhea in US
The cases showed high-level resistance to azithromycin and reduced susceptibility to ceftriaxone, a'troubling'sign, one official said.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2016 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Second Chance on Bladder US
“If you are given a second chance in life, don’t blow it,” you advise your eager resident. It has been an overwhelmingly busy day in the department. Interspersed between the motor vehicle collisions, hypoxic and hypotensive CHF exacerbations, and patients with florid sepsis, your team is trying to see and help all of the ankle pains, throat pains, and dysuria that have also walked through the waiting room doors. The neighborhood clinics are completely overbooked, and your department has been dealing with the overflow all week. Your resident has three charts in her hand and has just finished presenting the...
Source: EPMonthly.com - September 19, 2016 Category: Emergency Medicine Authors: Logan Plaster Tags: Uncategorized Source Type: news

Antibiotic-Resistant Gonorrhea Is A Looming Threat
The Centers for Disease Control and Prevention reported Thursday that Neisseria gonorrhoeae ― that is, the bacteria that causes gonorrhea ― could be developing resistance to our last-line antibiotics that treat it. The CDC’s current gold standard treatment for gonorrhea is a combination of two drugs, azithromycin and ceftriaxone, to ensure that if one drug doesn’t kill the bacteria, the other will finish the job. Now, a rise in antibiotic resistance among these two bacteria since 2014 has experts worried. “History has taught us that this bacteria has the ability to develop resistance to...
Source: Science - The Huffington Post - July 19, 2016 Category: Science Source Type: news

Antibiotic-Resistant N. gonorrhoeae May Be Increasing (FREE)
By the Editors Gonorrhea infections in the U.S. may be growing more resistant to the only recommended treatment, ceftriaxone plus … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 18, 2016 Category: Primary Care Source Type: news

This month’s toughest USMLE Step 2 question to master
Getting ready for the United States Medical Licensing Examination® (USMLE®) Step 2 is no easy feat, but we’re sharing expert insights to help give you a leg up. Take a look at the exclusive scoop on this month’s most-missed USMLE Step 2 test prep question. Think you have what it takes to rise above your peers? Test your USMLE knowledge, and view an expert video explanation of the answer from Kaplan Medical. Once you’ve got this question under your belt, be sure to test your knowledge with other posts in this series. Ready. Set. Go. This month’s question that stumped most students:...
Source: AMA Wire - June 28, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news

This month ’s toughest USMLE Step 2 question to master
Getting ready for the United States Medical Licensing Examination ® (USMLE®) Step 2 is no easy feat, but we’re sharing expert insights to help give you a leg up. Take a look at the exclusive scoop on this month’s most-missed USMLE Step 2 test prep question. Think you have what it takes to rise above your peers? Test your USMLE knowledge, and view an expert v ideo explanation of the answer from Kaplan Medical. Once you ’ve got this question under your belt, be sure to test your knowledge with  other posts in this series . Ready. Set. Go. This month ’s question that stumped most st...
Source: AMA Wire - June 28, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news

Warning issued over alarming rise in 'super-gonorrhoea' cases
"Doctors have expressed 'huge concern' that super-gonorrhoea has spread widely across England," BBC News reports. Public Health England issued the warning about the rise of a strain of gonorrhoea that has developed resistance to a widely used antibiotic.  What is gonorrhoea? Gonorrhoea is a sexually transmitted infection (STI) caused by bacteria called Neisseria gonorrhoeae or gonococcus. It used to be known as "the clap". The bacteria are mainly found in discharge from the penis and vaginal fluid. It is easily passed between people through: unprotected vaginal, oral or anal sex sh...
Source: NHS News Feed - April 18, 2016 Category: Consumer Health News Tags: Medical practice Lifestyle/exercise Medication QA articles Source Type: news

At What Age Does the Risk of Infant Listeria Infection Decrease?
Discussion Neonatal bacterial infections are commonly caused by Group B Streptococcus, enteric gram-negative organisms such as Escherichia coli, coagulase negative Staphylococcus, Listeria monocytogenes and Haemophilus influenza. Infections are usually because of transplacental infection or ascending infection from the mother’s genitourinary tract. Empiric treatment for suspected sepsis for neonates is usually combined IV aminoglycoside and expanded-spectrum penicillin antibiotic therapy in the US and Canada and this combination specifically covers for Listeria. Listeria monocytogenes was first discovered in 1927 an...
Source: PediatricEducation.org - January 25, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Emerging Extended-Spectrum Cephalosporin Resistance in
Over the last several decades, Neisseria gonorrhoeae has sequentially developed resistance to the agents recommended by the CDC and the Public Health Service for the treatment of gonorrhea. During the 1970s and through the 1990s, penicillin, tetracyclines, and the fluoroquinolones were recommended and subsequently removed as the therapy of choice for gonorrhea, leaving intramuscular ceftriaxone and the oral cephalosporin cefixime as the sole agents recommended for treatment of gonorrhea in 2010. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - January 12, 2016 Category: Microbiology Authors: William M. Janda Source Type: news

What Are Risk Factors for Cholelithiasis?
Discussion Bile is produced by the liver to aid absorption of fat soluble vitamins and lipids from the gastrointestinal tract and to transport bilirubin, cholesterol and other substances to the gastrointestinal tract. Bile is the main form of cholesterol excretion. Gallstones or cholelithiasis form when the balance of substances within the hepatobiliary tract favors supersaturation with crystal formation and gallstone formation. It is a dynamic state of affairs as gallstones can form and also have a high rate of resorption of up to 50%. Gallstones 3 mm are called gallstones. Gallstones, while not as common as adult popula...
Source: PediatricEducation.org - January 4, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Resistant gonorrhea rates high in China, raise concerns in U.S.
SAN DIEGO – Experts in the field of Neisseria gonorrhoeae antimicrobial resistance are warily watching developments in China, where rates of nonsusceptibility to ceftriaxone are reportedly shooting through the roof. In the United States at present, gonococcal resistance to ceftriaxone is... (Source: Skin and Allergy News)
Source: Skin and Allergy News - November 15, 2015 Category: Dermatology Source Type: news

2014 saw spike in antibiotic-resistant gonorrhea
Enhanced gonorrhea susceptibility to third-generation cephalosporin-class antibiotic agents such as injectable ceftriaxone and oral cefixime may have been temporary, according to a retrospective analysis published in the Nov. 3 issue of JAMA. The findings of
Source: Skin and Allergy News - November 3, 2015 Category: Dermatology Source Type: news

ACOG Advocates Dual Therapy for Gonococcal InfectionsACOG Advocates Dual Therapy for Gonococcal Infections
Ceftriaxone plus azithromycin is the recommended first-line regimen in the face of antimicrobial resistance. Medscape Medical News (Source: Medscape PublicHealth Headlines)
Source: Medscape PublicHealth Headlines - October 22, 2015 Category: Primary Care Tags: Ob/Gyn & Women ' s Health News Source Type: news

Class I Medical Device Recall: Siemens Healthcare Diagnostics, Rapid Gram Negative Combo Panels - May Produce Incorrect Results
Reason for Recall: Incorrect test results may occur for the following antibiotics: Aztreonam, Cefotaxime, Ceftazidime, and Ceftriaxone. The test may report certain bacteria as sensitive to one of these antibiotics when the bacteria are actually resistant. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - December 1, 2014 Category: Medical Equipment Source Type: news